A 55-year-old man comes to the physician with a 3-month history of headache, periodic loss of vision, and easy bruising. Physical examination shows splenomegaly. His hemoglobin concentration is 13.8 g/dL, leukocyte count is 8000/mm3, and platelet count is 995,000/mm3. Bone marrow biopsy shows markedly increased megakaryocytes with hyperlobulated nuclei. Genetic analysis shows upregulation of the JAK-STAT genes. The pathway encoded by these genes is also physiologically responsible for signal transmission of which of the following hormones?
Q122
A 4-year-old boy with a rash is brought in by his mother. The patient’s mother says that his symptoms started acutely a few hours ago after they had eaten shellfish at a restaurant which has progressively worsened. She says that the rash started with a few bumps on his neck and chest but quickly spread to involve his arms and upper torso. The patient says the rash makes him uncomfortable and itches badly. He denies any fever, chills, night sweats, dyspnea, or similar symptoms in the past. Past medical history is significant for a history of atopic dermatitis at the age of 9 months which was relieved with some topical medications. The patient is afebrile and his vital signs are within normal limits. On physical examination, the rash consists of multiple areas of erythematous, raised macules that blanch with pressure as shown in the exhibit (see image). There is no evidence of laryngeal swelling and his lungs are clear to auscultation. Which of the following is the best course of treatment for this patient’s most likely condition?
Q123
A 42-year-old female complains of feeling anxious and worrying about nearly every aspect of her daily life. She cannot identify a specific cause for these symptoms and admits that this tension is accompanied by tiredness and difficulty falling asleep. To treat this problem, the patient is prescribed sertraline. She endorses a mild improvement with this medication, and over the next several months, her dose is increased to the maximum allowed dose with modest improvement. Her psychiatrist adds an adjunctive treatment, a medication which notably lacks any anticonvulsant or muscle relaxant properties. This drug most likely acts at which of the following receptors?
Q124
A 5-year-old girl is brought to the physician for evaluation of a pruritic rash on her face and extremities for the last year that increases with sun exposure. Her parents report that she often seems clumsy and has had several falls in the last two weeks. Physical examination shows an erythematous, scaly rash with hyperpigmentation over the nasal bridge and cheeks as well as on the dorsal forearms and hands. Urinalysis shows high levels of neutral amino acids. The most appropriate treatment for this patient's condition includes administration of an agent that is associated with which of the following adverse effects?
Q125
A 25-year-old man is brought to the emergency department by paramedics with a seizure lasting over 30 minutes. The patient's neighbors found him outside his apartment with all four limbs flailing and not responding to his name. No significant past medical history. On physical examination, the patient continues to be unresponsive and slightly cyanotic with irregular breathing. His teeth are clenched tightly. Intravenous glucose and an anticonvulsant medication are administered. Which of the following is the mechanism of action of the drug that was most likely administered to stop this patient’s seizure?
Q126
A 23-year-old woman makes an appointment with a dermatologist for treatment of acne. As a result, she feels uncomfortable in public and feels as though everyone is looking at the pimples on her face. She cleans her face several times a day with face wash and avoids using make-up. She has tried many face creams and scar removal creams to help improve the condition of her skin, but nothing has worked. On examination, she has pustular acne on her cheeks and forehead. The physician prescribes an antibiotic along with isotretinoin. Which of the following drugs would you recommend in conjunction with isotretinoin?
Q127
A 67-year-old man presents to his primary care physician primarily complaining of a tremor. He said that his symptoms began approximately 1 month ago, when his wife noticed his right hand making "abnormal movements" while watching television. His tremor worsens when he is distracted and improves with purposeful action, such as brushing his teeth or combing his hair. He reports having occasional headaches during times of stress. His wife notices he walks with "poor" posture and he finds himself having trouble staying asleep. He has a past medical history of migraine, generalized anxiety disorder, hypertension, and hyperlipidemia. On physical exam, the patient has a tremor that improves with extension of the arm. On gait testing, the patient has a stooped posture and takes short steps. Which of the following is the most effective treatment for this patient's symptoms?
Q128
A 20-year-old college student presents to the emergency room complaining of insomnia for the past 48 hours. He explains that although his body feels tired, he is "full of energy and focus" after taking a certain drug an hour ago. He now wants to sleep because he is having hallucinations. His vital signs are T 100.0 F, HR 110 bpm, and BP of 150/120 mmHg. The patient states that he was recently diagnosed with "inattentiveness." Which of the following is the mechanism of action of the most likely drug causing the intoxication?
Q129
A scientist is studying a protein that is present on the plasma membrane of cells. He therefore purifies the protein in a lipid bilayer and subjects it to a number of conditions. His investigations show that the protein has the following properties:
1) It is able to change ion concentrations across the membrane without addition of ATP to the solution.
2) Its activity increases linearly with substrate concentration without any saturation even at mildly supraphysiologic conditions.
3) In some states the protein leads to an ion concentration change; whereas, it has no effect in other states.
4) Changing the electrical charge across the membrane does not affect whether the protein has activity.
5) Adding a small amount of an additional substance to the solution reliably increases the protein's activity.
These findings are consistent with a protein with which of the following functions?
Q130
A 31-year-old man presents to his primary care physician endorsing three months of decreased sleep. He reports an inability to fall asleep; although once asleep, he generally sleeps through the night and wakes up at a desired time. He has instituted sleep hygiene measures, but this has not helped. He has not felt anxious or depressed and is otherwise healthy. You prescribe him a medication that has the potential side effect of priapism. From which of the following locations is the neurotransmitter affected by this medication released?
Cholinergic/Adrenergic drugs US Medical PG Practice Questions and MCQs
Question 121: A 55-year-old man comes to the physician with a 3-month history of headache, periodic loss of vision, and easy bruising. Physical examination shows splenomegaly. His hemoglobin concentration is 13.8 g/dL, leukocyte count is 8000/mm3, and platelet count is 995,000/mm3. Bone marrow biopsy shows markedly increased megakaryocytes with hyperlobulated nuclei. Genetic analysis shows upregulation of the JAK-STAT genes. The pathway encoded by these genes is also physiologically responsible for signal transmission of which of the following hormones?
A. Oxytocin
B. Adrenocorticotropic hormone
C. Prolactin (Correct Answer)
D. Cortisol
E. Insulin
Explanation: ***Prolactin***
- Prolactin utilizes the **JAK-STAT signaling pathway** to exert its effects on target cells, particularly in the mammary glands.
- The **JAK-STAT pathway** is crucial for cell growth, differentiation, and immune response, and its dysregulation is linked to myeloproliferative disorders like those involving megakaryocyte proliferation.
*Oxytocin*
- Oxytocin primarily acts through **G-protein coupled receptors** that activate the phospholipase C/inositol triphosphate pathway, not the JAK-STAT pathway.
- Its main roles involve uterine contraction and milk ejection, which are distinct from the cellular proliferation regulated by JAK-STAT.
*Adrenocorticotropic hormone*
- ACTH binds to **G-protein coupled receptors** in the adrenal cortex, stimulating adenylyl cyclase and increasing cAMP levels.
- This mechanism of action is distinct from the tyrosine kinase activity characteristic of the JAK-STAT pathway.
*Cortisol*
- Cortisol, a steroid hormone, primarily acts via **intracellular glucocorticoid receptors** that translocate to the nucleus to regulate gene transcription.
- Its signaling mechanism involves direct gene regulation rather than a membrane-bound receptor-kinase cascade like JAK-STAT.
*Insulin*
- Insulin signals through a **receptor tyrosine kinase**, which, upon binding, autophosphorylates and initiates a cascade involving IRS proteins and the PI3K/Akt and MAPK pathways.
- While it involves tyrosine phosphorylation, it is distinct from the JAK-STAT pathway, which is primarily activated by cytokine and growth hormone type I receptors.
Question 122: A 4-year-old boy with a rash is brought in by his mother. The patient’s mother says that his symptoms started acutely a few hours ago after they had eaten shellfish at a restaurant which has progressively worsened. She says that the rash started with a few bumps on his neck and chest but quickly spread to involve his arms and upper torso. The patient says the rash makes him uncomfortable and itches badly. He denies any fever, chills, night sweats, dyspnea, or similar symptoms in the past. Past medical history is significant for a history of atopic dermatitis at the age of 9 months which was relieved with some topical medications. The patient is afebrile and his vital signs are within normal limits. On physical examination, the rash consists of multiple areas of erythematous, raised macules that blanch with pressure as shown in the exhibit (see image). There is no evidence of laryngeal swelling and his lungs are clear to auscultation. Which of the following is the best course of treatment for this patient’s most likely condition?
A. No treatment necessary
B. Cetirizine (Correct Answer)
C. Prednisone
D. Topical corticosteroids
E. IM epinephrine
Explanation: ***Cetirizine***
- The patient presents with **acute urticaria (hives)**, characterized by an **itchy, erythematous, raised, blanching rash** that developed rapidly after consuming shellfish. This suggests an **IgE-mediated allergic reaction**.
- **Cetirizine** is a **second-generation H1-antihistamine** that effectively blocks histamine release, alleviating symptoms like itching and rash, and is the first-line treatment for acute urticaria.
*No treatment necessary*
- The patient is experiencing significant discomfort and itching from the rash, indicating that **symptomatic relief** is warranted.
- While acute urticaria can sometimes resolve spontaneously, the distress caused to the patient necessitates active intervention to improve comfort.
*Prednisone*
- **Systemic corticosteroids** like prednisone are typically reserved for **severe cases of urticaria**, chronic urticaria unresponsive to antihistamines, or when there are signs of **angioedema** or **anaphylaxis**.
- This patient's symptoms are confined to the skin without signs of laryngeal swelling or dyspnea, making corticosteroids an **overtreatment** at this stage.
*Topical corticosteroids*
- **Topical corticosteroids** are primarily used for inflammatory skin conditions like **atopic dermatitis** or contact dermatitis, and they do not effectively treat urticaria.
- Urticaria lesions are a result of dermal mast cell degranulation and histamine release, affecting the dermis rather than the epidermis, making topical agents largely ineffective for the **itch and wheals** of hives.
*IM epinephrine*
- **Intramuscular (IM) epinephrine** is indicated for **anaphylaxis** or severe allergic reactions with signs of systemic involvement, such as **bronchospasm**, **hypotension**, or **laryngeal edema**.
- This patient's vital signs are stable, and there is no evidence of airway compromise or systemic symptoms, so epinephrine is unnecessary and potentially harmful.
Question 123: A 42-year-old female complains of feeling anxious and worrying about nearly every aspect of her daily life. She cannot identify a specific cause for these symptoms and admits that this tension is accompanied by tiredness and difficulty falling asleep. To treat this problem, the patient is prescribed sertraline. She endorses a mild improvement with this medication, and over the next several months, her dose is increased to the maximum allowed dose with modest improvement. Her psychiatrist adds an adjunctive treatment, a medication which notably lacks any anticonvulsant or muscle relaxant properties. This drug most likely acts at which of the following receptors?
A. Beta adrenergic receptor
B. 5HT-1A receptor (Correct Answer)
C. GABA receptor
D. Alpha adrenergic receptor
E. Glycine receptor
Explanation: ***5HT-1A receptor***
- The patient's presentation of generalized anxiety disorder, treated with an SSRI (sertraline) and an adjunctive medication that lacks anticonvulsant or muscle relaxant properties, points to **buspirone**.
- **Buspirone** is a 5HT-1A partial agonist, commonly used as an augmenting agent in anxiety disorders, which explains the mechanism of action.
*Beta adrenergic receptor*
- Medications acting on **beta-adrenergic receptors** (e.g., propranolol) are typically used for situational anxiety or performance anxiety, not generalized anxiety disorder, and they primarily reduce physical symptoms like palpitations and tremors.
- While beta-blockers lack anticonvulsant or muscle relaxant properties, they are not typically considered a first-line adjunctive therapy for generalized anxiety after an SSRI failure.
*GABA receptor*
- Drugs acting on **GABA receptors** (e.g., benzodiazepines) are known for their anxiolytic, sedative, anticonvulsant, and muscle relaxant properties.
- The question explicitly states that the adjunctive medication "notably lacks any anticonvulsant or muscle relaxant properties," ruling out GABAergic drugs.
*Alpha adrenergic receptor*
- Medications targeting **alpha-adrenergic receptors** (e.g., clonidine) are sometimes used for anxiety associated with opiate withdrawal or PTSD, but are not a common adjunctive treatment for generalized anxiety disorder in this context.
- While they may lack anticonvulsant or muscle relaxant properties, their primary mechanism involves regulating sympathetic outflow rather than the specific mood and cognitive symptoms of GAD.
*Glycine receptor*
- The **glycine receptor** is an inhibitory ion channel, primarily found in the spinal cord and brainstem, involved in motor control and pain processing.
- Agonists of this receptor are not commonly used to treat anxiety disorders, and the described clinical scenario does not align with its therapeutic applications.
Question 124: A 5-year-old girl is brought to the physician for evaluation of a pruritic rash on her face and extremities for the last year that increases with sun exposure. Her parents report that she often seems clumsy and has had several falls in the last two weeks. Physical examination shows an erythematous, scaly rash with hyperpigmentation over the nasal bridge and cheeks as well as on the dorsal forearms and hands. Urinalysis shows high levels of neutral amino acids. The most appropriate treatment for this patient's condition includes administration of an agent that is associated with which of the following adverse effects?
A. Irreversible retinopathy
B. Pseudotumor cerebri
C. Facial flushing (Correct Answer)
D. Calcium oxalate kidney stones
E. Nephrocalcinosis
Explanation: ***Facial flushing***
- This patient's constellation of symptoms, including a photosensitive rash, ataxia, and excessive urinary excretion of neutral amino acids, is characteristic of **Hartnup disease**.
- Hartnup disease is treated with high-dose **niacin (vitamin B3)** supplementation, which can cause unpleasant but usually harmless facial flushing due to vasodilation.
*Irreversible retinopathy*
- This adverse effect is more commonly associated with chronic use of **hydroxychloroquine**, which is used in conditions like lupus or rheumatoid arthritis, not Hartnup disease.
- While visual disturbances can occur with some vitamin deficiencies or toxicities, **niacin** does not typically cause irreversible retinopathy.
*Pseudotumor cerebri*
- **Pseudotumor cerebri** (idiopathic intracranial hypertension) is a known adverse effect of certain medications, such as **isotretinoin**, and can be exacerbated by excessive Vitamin A intake.
- It is not a typical adverse effect associated with **niacin** supplementation used in Hartnup disease.
*Calcium oxalate kidney stones*
- **Calcium oxalate kidney stones** are associated with conditions causing hyperoxaluria, such as primary hyperoxaluria or malabsorption syndromes, but not typically with niacin supplementation.
- While some vitamins can affect renal stone formation (e.g., high-dose vitamin C can increase oxalate), it's not a primary adverse effect of **niacin**.
*Nephrocalcinosis*
- **Nephrocalcinosis** involves calcium deposition in the renal parenchyma and is associated with conditions causing hypercalcemia or hypercalciuria (e.g., hyperparathyroidism, sarcoidosis, distal renal tubular acidosis).
- It is not a common adverse effect of **niacin** therapy for Hartnup disease, which primarily involves malabsorption of specific amino acids.
Question 125: A 25-year-old man is brought to the emergency department by paramedics with a seizure lasting over 30 minutes. The patient's neighbors found him outside his apartment with all four limbs flailing and not responding to his name. No significant past medical history. On physical examination, the patient continues to be unresponsive and slightly cyanotic with irregular breathing. His teeth are clenched tightly. Intravenous glucose and an anticonvulsant medication are administered. Which of the following is the mechanism of action of the drug that was most likely administered to stop this patient’s seizure?
A. Blockage of voltage-gated calcium channels
B. Blockage of T-type calcium
C. Increase in frequency of chloride channel opening (Correct Answer)
D. Prolongation of chloride channel opening
E. Inactivation of sodium channels
Explanation: ***Increase in frequency of chloride channel opening***
- The patient is experiencing **status epilepticus** (seizure lasting >5 minutes or recurrent seizures without full recovery of consciousness), which requires rapid intervention, typically with a **benzodiazepine**.
- **Benzodiazepines** (e.g., lorazepam, diazepam) act by binding to the **GABA-A receptor** and increasing the **frequency of chloride channel opening**, leading to neuronal hyperpolarization and reduced excitability.
*Blockage of voltage-gated calcium channels*
- This mechanism is characteristic of **gabapentin** and **pregabalin**, which are used for **neuropathic pain** and adjunctive seizure therapy, but not typically as first-line for status epilepticus.
- Blocking voltage-gated calcium channels primarily reduces **neurotransmitter release**, which is a slower mechanism of action compared to GABAergic potentiation for acute seizure cessation.
*Blockage of T-type calcium*
- This is the primary mechanism of action for **ethosuximide**, which is used specifically for **absence seizures**.
- Absence seizures are brief, generalized non-convulsive seizures, distinct from the generalized tonic-clonic seizure described in the patient.
*Prolongation of chloride channel opening*
- This mechanism is associated with **barbiturates** (e.g., phenobarbital), which also act on the GABA-A receptor but cause a **prolonged opening** of the chloride channel at high concentrations.
- While barbiturates can be used for refractory status epilepticus, **benzodiazepines** are generally preferred as first-line due to a better safety profile and fewer side effects compared to barbiturates.
*Inactivation of sodium channels*
- This mechanism is characteristic of several anticonvulsant drugs, including **phenytoin, carbamazepine, and lamotrigine**.
- These drugs are typically used for **long-term seizure control** and prevention, not as first-line agents for aborting an ongoing status epilepticus, due to their slower onset of action.
Question 126: A 23-year-old woman makes an appointment with a dermatologist for treatment of acne. As a result, she feels uncomfortable in public and feels as though everyone is looking at the pimples on her face. She cleans her face several times a day with face wash and avoids using make-up. She has tried many face creams and scar removal creams to help improve the condition of her skin, but nothing has worked. On examination, she has pustular acne on her cheeks and forehead. The physician prescribes an antibiotic along with isotretinoin. Which of the following drugs would you recommend in conjunction with isotretinoin?
A. Vitamin B6
B. Antihypertensives
C. Statins
D. Oral contraceptives (Correct Answer)
E. Folic acid
Explanation: ***Oral contraceptives***
- **Isotretinoin** is **highly teratogenic**, causing severe birth defects, so effective contraception is mandatory for females of childbearing potential.
- **Oral contraceptives** are a common and effective method to prevent pregnancy during isotretinoin treatment.
*Vitamin B6*
- **Vitamin B6** (pyridoxine) is sometimes used for conditions like premenstrual syndrome or nausea, but it has **no direct role** in managing the side effects or enhancing the efficacy of isotretinoin.
- While essential for various bodily functions, it is **not a recommended co-treatment** with isotretinoin for acne or its associated risks.
*Antihypertensives*
- **Antihypertensives** are used to treat **high blood pressure**, a condition not indicated in this patient's presentation or directly linked to isotretinoin use.
- While isotretinoin can sometimes affect lipid profiles, it does **not typically cause hypertension** requiring this class of medication.
*Statins*
- **Statins** are prescribed to lower **cholesterol and triglyceride levels**, and while isotretinoin can cause **hyperlipidemia**, statins are generally not prescribed prophylactically.
- **Monitoring lipid levels** is standard practice with isotretinoin, and statins would only be considered if elevations are significant and persistent.
*Folic acid*
- **Folic acid** supplementation is crucial during pregnancy to prevent neural tube defects but has **no direct interaction** or complementary role with isotretinoin for acne treatment.
- While it's vital for women of childbearing age, it does **not address the immediate necessity for contraception** when taking isotretinoin.
Question 127: A 67-year-old man presents to his primary care physician primarily complaining of a tremor. He said that his symptoms began approximately 1 month ago, when his wife noticed his right hand making "abnormal movements" while watching television. His tremor worsens when he is distracted and improves with purposeful action, such as brushing his teeth or combing his hair. He reports having occasional headaches during times of stress. His wife notices he walks with "poor" posture and he finds himself having trouble staying asleep. He has a past medical history of migraine, generalized anxiety disorder, hypertension, and hyperlipidemia. On physical exam, the patient has a tremor that improves with extension of the arm. On gait testing, the patient has a stooped posture and takes short steps. Which of the following is the most effective treatment for this patient's symptoms?
A. Pramipexole
B. Carbidopa-levodopa (Correct Answer)
C. Trihexyphenidyl
D. Selegiline
E. Amantadine
Explanation: **Carbidopa-levodopa**
- The patient's symptoms (resting tremor improving with purposeful action, stooped posture, short steps, sleep disturbances) are highly indicative of **Parkinson's disease**. **Carbidopa-levodopa** is the **most effective symptomatic treatment** for motor symptoms in Parkinson's, especially in older patients or those with significant functional impairment.
- **Levodopa** is a precursor to dopamine and replaces deficient dopamine in the brain, while **carbidopa** prevents its peripheral breakdown, allowing more to reach the central nervous system and reducing side effects.
*Pramipexole*
- **Pramipexole** is a **dopamine agonist** which can be used, particularly in younger patients, to delay the need for levodopa, or as an adjunct. However, it is generally less effective than levodopa for severe motor symptoms.
- Dopamine agonists have a higher incidence of side effects like **hallucinations, edema, and impulse control disorders** compared to levodopa, especially in older patients.
*Trihexyphenidyl*
- **Trihexyphenidyl** is an **anticholinergic drug** primarily used for **tremor-dominant Parkinson's disease**, particularly in younger patients.
- It is generally contraindicated or used with extreme caution in older patients due to significant **anticholinergic side effects** such as confusion, memory impairment, and urinary retention, which would be problematic for a 67-year-old.
*Selegiline*
- **Selegiline** is a **MAO-B inhibitor** that slows the breakdown of dopamine in the brain. It can provide mild symptomatic benefit and may have neuroprotective properties.
- While useful for mild symptoms or as an adjunct, it is generally **not as potent or effective** as levodopa for managing the significant motor symptoms described.
*Amantadine*
- **Amantadine** is an **antiviral agent** that has mild antiparkinsonian effects, thought to involve N-methyl-D-aspartate (NMDA) receptor antagonism and dopamine release.
- It is often used for **mild symptoms** or specifically for **levodopa-induced dyskinesias**, but it is generally less effective than levodopa for primary motor symptoms.
Question 128: A 20-year-old college student presents to the emergency room complaining of insomnia for the past 48 hours. He explains that although his body feels tired, he is "full of energy and focus" after taking a certain drug an hour ago. He now wants to sleep because he is having hallucinations. His vital signs are T 100.0 F, HR 110 bpm, and BP of 150/120 mmHg. The patient states that he was recently diagnosed with "inattentiveness." Which of the following is the mechanism of action of the most likely drug causing the intoxication?
A. Blocks NMDA receptors
B. Activates mu opioid receptors
C. Displaces norepinephrine from secretory vesicles leading to norepinephrine depletion
D. Binds to cannabinoid receptors
E. Increases presynaptic dopamine and norepinephrine release from vesicles (Correct Answer)
Explanation: ***Increases presynaptic dopamine and norepinephrine releases from vesicles***
- The patient's presentation with **insomnia**, feeling "full of energy and focus," **hallucinations**, tachycardia (HR 110 bpm), and hypertension (BP 150/120 mmHg) after taking a drug, especially in the context of a recent diagnosis of "inattentiveness," strongly suggests **amphetamine intoxication**. Amphetamines are commonly prescribed for **ADHD**, and their mechanism involves increasing the release of **dopamine** and **norepinephrine** from presynaptic vesicles.
- This increased release of **catecholamines** leads to the stimulant effects observed, including heightened energy, improved focus, and the adverse effects of agitation, psychosis (hallucinations), and sympathetic overdrive.
*Blocks NMDA receptors*
- Drugs that block **NMDA receptors**, such as **phencyclidine (PCP)** or **ketamine**, can cause dissociative and hallucinatory effects.
- However, the patient's primary complaint of feeling "full of energy and focus" in the context of "inattentiveness" points more towards a classical stimulant rather than a dissociative anesthetic.
*Activates mu opioid receptors*
- Activating **mu opioid receptors** (e.g., by heroin, morphine, fentanyl) typically causes central nervous system **depression**, respiratory depression, miosis, and euphoria, not the stimulant and hyperactive state described.
- The patient's symptoms of increased energy, focus, and elevated vital signs are the opposite of opioid effects.
*Displaces norepinephrine from secretory vesicles leading to norepinephrine depletion*
- This mechanism is characteristic of drugs like **reserpine**, which deplete catecholamines and lead to sedative or antihypertensive effects, not the stimulant and sympathomimetic presentation described.
- Such a mechanism would cause a **decrease** in sympathetic activity, contrary to the patient's elevated heart rate and blood pressure.
*Binds to cannabinoid receptors*
- Binding to **cannabinoid receptors** (e.g., by marijuana)
typically leads to effects such as euphoria, altered perception, impaired memory, and sometimes anxiety or paranoia.
- While hallucinations can occur, the prominent "full of energy and focus" and significant sympathetic activation (tachycardia, hypertension) are not typical of cannabinoid intoxication.
Question 129: A scientist is studying a protein that is present on the plasma membrane of cells. He therefore purifies the protein in a lipid bilayer and subjects it to a number of conditions. His investigations show that the protein has the following properties:
1) It is able to change ion concentrations across the membrane without addition of ATP to the solution.
2) Its activity increases linearly with substrate concentration without any saturation even at mildly supraphysiologic conditions.
3) In some states the protein leads to an ion concentration change; whereas, it has no effect in other states.
4) Changing the electrical charge across the membrane does not affect whether the protein has activity.
5) Adding a small amount of an additional substance to the solution reliably increases the protein's activity.
These findings are consistent with a protein with which of the following functions?
A. Maintenance of resting sodium and potassium concentrations
B. Transporting water in the collecting duct of the kidney
C. Reabsorption of glucose in the proximal kidney tubule
D. Mediating neuronal to muscle end plate communication (Correct Answer)
E. Causing depolarization during action potentials
Explanation: **Mediating neuronal to muscle end plate communication**
- The properties described align with **ligand-gated ion channels**, which mediate communication at the neuromuscular junction. These channels open in response to a **neurotransmitter** (the "additional substance"), allowing ion flow without direct ATP hydrolysis.
- The "some states" where it has no effect and "other states" where it leads to ion concentration change refer to its closed and open conformational states, dependent on ligand binding. The lack of saturation and independence from electrical charge are features of some channel kinetics.
*Maintenance of resting sodium and potassium concentrations*
- This function is primarily carried out by the **Na+/K+ ATPase pump**, which is an **active transporter** requiring ATP hydrolysis for its function, contradicting property (1).
- The Na+/K+ ATPase transports ions against their concentration gradients and would be affected by changes in ATP availability.
*Reabsorption of glucose in the proximal kidney tubule*
- Glucose reabsorption primarily involves **Na+-glucose cotransporters (SGLTs)**, which are secondary active transporters. While they don't directly use ATP, their activity is linked to the Na+ gradient maintained by Na+/K+ ATPase, and they can show saturation kinetics.
- SGLTs are symporters that move glucose and Na+ in the same direction and exhibit saturation at high glucose concentrations.
*Transporting water in the collecting duct of the kidney*
- Water transport in the collecting duct is mediated by **aquaporins**, which are passive water channels. Their activity is regulated by **vasopressin** (ADH), but they primarily transport water, not ions.
- Aquaporins do not typically impact ion concentrations directly and their activity is usually quite specific to water movement.
*Causing depolarization during action potentials*
- Depolarization during action potentials is caused by the opening of **voltage-gated sodium channels**. These channels are directly affected by changes in **electrical charge** across the membrane, contradicting property (4).
- Voltage-gated channels exhibit specific thresholds for activation and inactivation based on membrane potential.
Question 130: A 31-year-old man presents to his primary care physician endorsing three months of decreased sleep. He reports an inability to fall asleep; although once asleep, he generally sleeps through the night and wakes up at a desired time. He has instituted sleep hygiene measures, but this has not helped. He has not felt anxious or depressed and is otherwise healthy. You prescribe him a medication that has the potential side effect of priapism. From which of the following locations is the neurotransmitter affected by this medication released?
A. Locus ceruleus
B. Substantia nigra
C. Posterior pituitary
D. Raphe nucleus (Correct Answer)
E. Nucleus accumbens
Explanation: ***Raphe nucleus***
- The patient's symptoms of **insomnia** without anxiety or depression, despite good sleep hygiene, suggest a potential for prescribing **trazodone**. Trazodone is an antidepressant with **sedating properties** that acts as a serotonin receptor antagonist and reuptake inhibitor.
- The **raphe nucleus** is the primary source of **serotonin** in the brain, and trazodone primarily affects serotonergic pathways, with priapism being a known but rare side effect associated with alpha-1 adrenergic blockade.
*Locus ceruleus*
- The **locus ceruleus** is the main source of **norepinephrine** in the brain, involved in arousal, attention, and stress responses.
- While norepinephrine plays a role in sleep-wake cycles, it is not the primary neurotransmitter targeted by medications commonly associated with priapism for insomnia management in this context.
*Substantia nigra*
- The **substantia nigra** is a brain structure that produces **dopamine** and is primarily involved in motor control, with its degeneration leading to Parkinson's disease.
- This region and its neurotransmitter are not typically associated with the treatment of insomnia or the specific side effect of priapism.
*Posterior pituitary*
- The **posterior pituitary** gland releases **oxytocin** and **vasopressin** (ADH), which are hormones synthesized in the hypothalamus.
- This structure is part of the endocrine system and is not directly involved in the central nervous system pathways targeted by medications for insomnia with the potential for priapism.
*Nucleus accumbens*
- The **nucleus accumbens** is a key component of the **reward pathway** in the brain, primarily utilizing **dopamine** and involved in motivation, pleasure, and addiction.
- While dopamine has some modulatory roles in sleep, it is not the primary target for effective insomnia treatment or associated with the specific side effects mentioned.